Image-Based AI Touted as a New Weapon Against Rare Cancers
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge
The pandemic may have set the stage for a jump in infections from these four nemeses
Bringing Clinical Mass Spectrometry into Routine Medical Laboratory Testing
Roche experts discuss the company’s recently launched automated solution and how it will bring mass spec to more patients
The Benefits of Penetration Tests in Labs
Cybersecurity expert explains the importance of such assessments, which simulate malicious attacks to identify IT vulnerabilities.
Automating Your Clinical Laboratory
How clinical laboratories can get started in automation—and what to consider when doing so.
Expert Q&A: Clinical Lab Automation Trends and Tips for Implementation
Laboratory leader Ihab Abumuhor discusses recent lab automation-related developments and the keys to successful implementation.
Challenges and Opportunities in Lab Automation
As technology advances and testing demand grows, automation and AI are increasingly making their way into the clinical lab.
Recent FDA Approvals Show Growing Sophistication of At-Home Tests
Once confined to areas such as pregnancy testing, these assays can now be used to detect STIs and other health issues.
At-Home Answers in Infectious Disease
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Expert Q&A: Adapting to the Expanding Market of At-Home Testing
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Screening Shortfalls and Self-Collected Samples
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Advancements in Antimicrobial Susceptibility Testing: Part 2
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
Diagnostics Pipeline: FDA Opens Path for Blood Tests Assessing Genetic Cancer Risk
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
